Report Detail

Pharma & Healthcare Global Companion Animal Pharmaceutical Market Growth (Status and Outlook) 2021-2026

  • RnM4314446
  • |
  • 03 May, 2021
  • |
  • Global
  • |
  • 104 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Companion Animal Pharmaceutical Market Size 2016-2026
    • 2.1.2 Companion Animal Pharmaceutical Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 Companion Animal Pharmaceutical Segment by Indication
    • 2.2.1 Infectious Diseases
    • 2.2.2 Infectious Diseases
    • 2.2.3 Pain
    • 2.2.4 Orthopedic Diseases
    • 2.2.5 Behavioral Diseases
    • 2.2.6 Other Indications
  • 2.3 Companion Animal Pharmaceutical Market Size by Indication
    • 2.3.1 Global Companion Animal Pharmaceutical Market Size CAGR by Indication
    • 2.3.2 Global Companion Animal Pharmaceutical Market Size Market Share by Indication (2016-2021)
  • 2.4 Companion Animal Pharmaceutical Segment by Application
    • 2.4.1 Dogs
    • 2.4.2 Cats
    • 2.4.3 Other
  • 2.5 Companion Animal Pharmaceutical Market Size by Application
    • 2.5.1 Global Companion Animal Pharmaceutical Market Size CAGR by Application
    • 2.5.2 Global Companion Animal Pharmaceutical Market Size Market Share by Application (2016-2021)

3 Companion Animal Pharmaceutical Market Size by Players

  • 3.1 Companion Animal Pharmaceutical Market Size Market Share by Players
    • 3.1.1 Global Companion Animal Pharmaceutical Revenue by Players (2019-2021E)
    • 3.1.2 Global Companion Animal Pharmaceutical Revenue Market Share by Players (2019-2021E)
  • 3.2 Global Companion Animal Pharmaceutical Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Companion Animal Pharmaceutical by Regions

  • 4.1 Companion Animal Pharmaceutical Market Size by Regions (2016-2021)
  • 4.2 Americas Companion Animal Pharmaceutical Market Size Growth (2016-2021)
  • 4.3 APAC Companion Animal Pharmaceutical Market Size Growth (2016-2021)
  • 4.4 Europe Companion Animal Pharmaceutical Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa Companion Animal Pharmaceutical Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas Companion Animal Pharmaceutical Market Size by Country (2016-2021)
  • 5.2 Americas Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
  • 5.3 Americas Companion Animal Pharmaceutical Market Size by Application (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Companion Animal Pharmaceutical Market Size by Region (2016-2021)
  • 6.2 APAC Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
  • 6.3 APAC Companion Animal Pharmaceutical Market Size by Application (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Companion Animal Pharmaceutical by Country (2016-2021)
  • 7.2 Europe Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
  • 7.3 Europe Companion Animal Pharmaceutical Market Size by Application (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Companion Animal Pharmaceutical by Region (2016-2021)
  • 8.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
  • 8.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global Companion Animal Pharmaceutical Market Forecast

  • 10.1 Global Companion Animal Pharmaceutical Forecast by Regions (2021-2026)
    • 10.1.1 Global Companion Animal Pharmaceutical Forecast by Regions (2021-2026)
    • 10.1.2 Americas Companion Animal Pharmaceutical Forecast
    • 10.1.3 APAC Companion Animal Pharmaceutical Forecast
    • 10.1.4 Europe Companion Animal Pharmaceutical Forecast
    • 10.1.5 Middle East & Africa Companion Animal Pharmaceutical Forecast
  • 10.2 Americas Companion Animal Pharmaceutical Forecast by Countries (2021-2026)
    • 10.2.1 United States Companion Animal Pharmaceutical Market Forecast
    • 10.2.2 Canada Companion Animal Pharmaceutical Market Forecast
    • 10.2.3 Mexico Companion Animal Pharmaceutical Market Forecast
    • 10.2.4 Brazil Companion Animal Pharmaceutical Market Forecast
  • 10.3 APAC Companion Animal Pharmaceutical Forecast by Region (2021-2026)
    • 10.3.1 China Companion Animal Pharmaceutical Market Forecast
    • 10.3.2 Japan Companion Animal Pharmaceutical Market Forecast
    • 10.3.3 Korea Companion Animal Pharmaceutical Market Forecast
    • 10.3.4 Southeast Asia Companion Animal Pharmaceutical Market Forecast
    • 10.3.5 India Companion Animal Pharmaceutical Market Forecast
    • 10.3.6 Australia Companion Animal Pharmaceutical Market Forecast
  • 10.4 Europe Companion Animal Pharmaceutical Forecast by Country (2021-2026)
    • 10.4.1 Germany Companion Animal Pharmaceutical Market Forecast
    • 10.4.2 France Companion Animal Pharmaceutical Market Forecast
    • 10.4.3 UK Companion Animal Pharmaceutical Market Forecast
    • 10.4.4 Italy Companion Animal Pharmaceutical Market Forecast
    • 10.4.5 Russia Companion Animal Pharmaceutical Market Forecast
  • 10.5 Middle East & Africa Companion Animal Pharmaceutical Forecast by Region (2021-2026)
    • 10.5.1 Egypt Companion Animal Pharmaceutical Market Forecast
    • 10.5.2 South Africa Companion Animal Pharmaceutical Market Forecast
    • 10.5.3 Israel Companion Animal Pharmaceutical Market Forecast
    • 10.5.4 Turkey Companion Animal Pharmaceutical Market Forecast
    • 10.5.5 GCC Countries Companion Animal Pharmaceutical Market Forecast
  • 10.6 Global Companion Animal Pharmaceutical Forecast by Indication (2021-2026)
  • 10.7 Global Companion Animal Pharmaceutical Forecast by Application (2021-2026)

11 Key Players Analysis

  • 11.1 Zoetis
    • 11.1.1 Zoetis Company Information
    • 11.1.2 Zoetis Companion Animal Pharmaceutical Product Offered
    • 11.1.3 Zoetis Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Zoetis Main Business Overview
    • 11.1.5 Zoetis Latest Developments
  • 11.2 Boehringer Ingelheim
    • 11.2.1 Boehringer Ingelheim Company Information
    • 11.2.2 Boehringer Ingelheim Companion Animal Pharmaceutical Product Offered
    • 11.2.3 Boehringer Ingelheim Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 Boehringer Ingelheim Main Business Overview
    • 11.2.5 Boehringer Ingelheim Latest Developments
  • 11.3 Merck Animal Health
    • 11.3.1 Merck Animal Health Company Information
    • 11.3.2 Merck Animal Health Companion Animal Pharmaceutical Product Offered
    • 11.3.3 Merck Animal Health Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 Merck Animal Health Main Business Overview
    • 11.3.5 Merck Animal Health Latest Developments
  • 11.4 Elanco Animal Health
    • 11.4.1 Elanco Animal Health Company Information
    • 11.4.2 Elanco Animal Health Companion Animal Pharmaceutical Product Offered
    • 11.4.3 Elanco Animal Health Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Elanco Animal Health Main Business Overview
    • 11.4.5 Elanco Animal Health Latest Developments
  • 11.5 Bayer Animal Health
    • 11.5.1 Bayer Animal Health Company Information
    • 11.5.2 Bayer Animal Health Companion Animal Pharmaceutical Product Offered
    • 11.5.3 Bayer Animal Health Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Bayer Animal Health Main Business Overview
    • 11.5.5 Bayer Animal Health Latest Developments
  • 11.6 Virbac
    • 11.6.1 Virbac Company Information
    • 11.6.2 Virbac Companion Animal Pharmaceutical Product Offered
    • 11.6.3 Virbac Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Virbac Main Business Overview
    • 11.6.5 Virbac Latest Developments
  • 11.7 Dechra Veterinary Products
    • 11.7.1 Dechra Veterinary Products Company Information
    • 11.7.2 Dechra Veterinary Products Companion Animal Pharmaceutical Product Offered
    • 11.7.3 Dechra Veterinary Products Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Dechra Veterinary Products Main Business Overview
    • 11.7.5 Dechra Veterinary Products Latest Developments
  • 11.8 Ceva
    • 11.8.1 Ceva Company Information
    • 11.8.2 Ceva Companion Animal Pharmaceutical Product Offered
    • 11.8.3 Ceva Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 Ceva Main Business Overview
    • 11.8.5 Ceva Latest Developments
  • 11.9 Vetoquinol
    • 11.9.1 Vetoquinol Company Information
    • 11.9.2 Vetoquinol Companion Animal Pharmaceutical Product Offered
    • 11.9.3 Vetoquinol Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 Vetoquinol Main Business Overview
    • 11.9.5 Vetoquinol Latest Developments
  • 11.10 Meiji
    • 11.10.1 Meiji Company Information
    • 11.10.2 Meiji Companion Animal Pharmaceutical Product Offered

According to this latest study, the 2021 growth of Companion Animal Pharmaceutical will have significant change from previous year. By the most conservative estimates of global Companion Animal Pharmaceutical market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the Companion Animal Pharmaceutical market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Companion Animal Pharmaceutical market by product type, application, key players and key regions and countries.

Segmentation by indication: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other Indications

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Dogs
Cats
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell


Summary:
Get latest Market Research Reports on Companion Animal Pharmaceutical. Industry analysis & Market Report on Companion Animal Pharmaceutical is a syndicated market report, published as Global Companion Animal Pharmaceutical Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of Companion Animal Pharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,500.00
$7,000.00
2,520.00
5,040.00
2,901.50
5,803.00
382,655.00
765,310.00
258,685.00
517,370.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report